Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/19
Title: Chitinase-3-like protein 1: reference interval of a healthy population and its diagnostic value for liver fibrosis in Pakistan
Authors: Faryal Husnain
Omar Rasheed Chughtai
Shakeel Ashraf
Muhammad Dilawar Khan
A.S. Chughtai
Muhammad Usman
Keywords: Chitinase-3-like protein 1
cirrhosis
hepatic fibrosis
reference interval
non-alcoholic fatty liver disease (NAFLD)
non-alcoholic steatohepatitis (NASH)
hepatocellular carcinoma
Issue Date: 2021
Publisher: Biomedica - Official Journal of University of Health Sciences, Lahore, Pakistan
Abstract: Background and Objective: Chitinase-3-like protein 1 (CHI3L1) is an upcoming biomarker for the diagnosis of liver fibrosis. The reference intervals (RIs) for CHI3L1 have not been established in the Pakistani population. Thus, this study aimed to determine the RIs in our population and the cut-off value for diagnosis of hepatic fibrosis. Methods: This is a cross-sectional study. A total of 408 participants (202 healthy and 206 diagnosed liver fibrosis cases) were recruited. Serum CHI3L1 level was measured on CHI3L1 kits (Proprium Biotech Co. Ltd) by manual enzyme-linked immunosorbent assay. The RIs were estimated by percentile and working normal method. Results: The distribution of CHI3L1 values showed no remarkable variation with gender and age. The 95% RI of CHI3L1 was 12.80-81.80 ng/ ml in healthy Pakistani subjects and the cut-off for the diagnosis was 102.12 ng/ml in hepatic fibrosis cases. Conclusion: The RIs in healthy adults and the cut-off for the diagnosis of hepatic fibrosis of serum CHI3L1 were determined in a selective adult Pakistani population. This will be a useful reference for further local and international studies.
URI: http://localhost:8080/xmlui/handle/123456789/19
Appears in Collections:Chemical Pathology

Files in This Item:
File Description SizeFormat 
biomedica-499.pdf255.4 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.